Available company data, source links and archived checks for Fusion Finance Limited. Read each source and date: a past check is not a fresh review, and some earlier figures have incomplete source details.
Quarter ended 2026-06-30 · standalone · Company filing
| Quarter | Revenue / income | YoY | Profit | YoY | Net margin | Source |
|---|---|---|---|---|---|---|
| Jun 2026 | Revenue: ₹458 cr | +5.5% | Net profit: ₹62 cr | — | 13.6% | Company filing source |
| Mar 2026 | Revenue: ₹424 cr | -9.0% | Net profit: ₹114 cr | — | 26.9% | Company filing source |
| Dec 2025 | Revenue: ₹416 cr | — | Net profit: ₹14 cr | — | 3.4% | Company filing source |
| Sep 2025 | Revenue: ₹416 cr | — | Net profit: ₹-22 cr | — | -5.3% | Company filing source |
| Jun 2025 | Revenue: ₹434 cr | -36.9% | Net profit: ₹-92 cr | — | -21.2% | Company filing source |
| Mar 2025 | Revenue: ₹466 cr | — | Net profit: ₹-165 cr | — | -35.3% | Company filing source |
YoY means change from the same quarter a year earlier. — means no comparable figure is available. Older entries with incomplete source details have not been revalidated under the current checks.
Annexure-A
Details of information pursuant to Regulation 30 and Regulation 51 of SEBI LODR Regulations read with SEBI Master Circular No. SEBI/HO/49/14/14(7)2025-CFDPOD2/I/3762/2026
| S. No. | Particulars | Details |
|---|---|---|
| 1. | Details of options granted | Grant of 94,600 stock options to the eligible employees of the Company under ESOP 2023. |
| 2. | Whether the scheme is in terms of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 (if applicable) | Yes, the scheme is in compliance with the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. |
| 3. | Total number of shares covered by these options | 94,600 (Ninety-Four Thousand Six Hundred Only) |
| 4. | Pricing formula | The aforesaid stock options have been granted at an exercise price of INR 188.18/- per stock option (closing price on the National Stock Exchange of India Limited, on September 15, 2026). |
| 5. | Options Vested/ Vesting Schedule | The options shall vest not before 1 year from the Grant Date and not after maximum Vesting Period as prescribed in the ESOP 2023. |
| 6. | Time within which option may be exercised | The Exercise period shall be 8 (Eight) years from the date of vesting of options. |
| 7. | Options exercised | Not Applicable |
| 8. | Money realized by exercise of options | Not Applicable |
| 9. | The total number of shares arising as a result of exercise of option | Not Applicable |
| 10. | Options lapsed | Not Applicable |
| 11. | Variation of terms of options | Not Applicable |
| 12. | Brief details of significant terms | Not Applicable |
| 13. | Subsequent changes or cancellation or exercise of such options | Not Applicable |
| 14. | Diluted earnings per share pursuant to issue of equity shares on exercise of options. | Not Applicable |
FUSION: standalone net profit for the quarter ending 30 June 2026 was ₹62.41 crore.
FUSION: standalone revenue changed by 5.5% in the quarter ending 30 June 2026, compared with the quarter ending 2025-06-30.
FUSION: standalone revenue for the quarter ending 30 June 2026 was ₹458.17 crore.
For options exercised, money realized by exercise of options, total number of shares arising as a result of exercise of option, options lapsed, variation of terms of options, brief details of significant terms, subsequent changes or cancellation or exercise of such options, and diluted earnings per share pursuant to issue of equity shares on exercise of options, the disclosure states 'Not Applicable'.
Keep its available filings, dated fact checks and disclosure alerts together. Your saved country sets your market and its research schedule.
Start free — first week on us →Company data and archived claim checks are shown with available sources. Check the source and date before relying on a figure. This is not investment advice or a recommendation. Investment in securities markets is subject to market risks. Research on this site is produced with substantial use of AI. Terms, disclosures and grievances